FDA 510(k) FDA class 2 Substantially Equivalent 🇺🇸 United States

SCIMEDX PHASE II PR3 IGG ANTIBODY EIA

K Number: K010287 · Decision Mar 16, 2001
Classifications
1
FEI Numbers
26
Registration Numbers
26
Same Product Code
73
Applicant Total
14
Review Days
44

Research this 510(k) in seconds

The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.

Free to try · every answer cites its records

Basic Information

Device Name
SCIMEDX PHASE II PR3 IGG ANTIBODY EIA
K Number
K010287
Device Class
FDA class 2
Clearance Type
Traditional
Regulation Number
866.5660
Medical Specialty
Immunology
Decision
Substantially Equivalent
Statement or Summary
Statement
Applicant
Scimedx Corp.
Date Received
January 31, 2001
Decision Date
March 16, 2001
Product Code
MOB
Advisory Committee
Immunology
Review Advisory Committee
IM
Third Party
N

Classifications

This FDA 510(k) entry is associated with 1 FDA classification via its product code.

Product Code Device Name
MOB Test System, Antineutrophil Cytoplasmic Antibodies (Anca)

Similar 510(k) Clearances

Other 510(k) clearances with the same product code (MOB), ordered by most recent decision date.

View all

Other Clearances by Scimedx Corp.

K Number Device Name
K011348 PHASE II GBM IGG ANTIBODY EIA TEST
K011082 TPO IGG ANTIBODY EIA TEST
K010625 EUROSPITAL EU-TTG IGA UMANA
K010289 SCIMEDX PHASE II MPO IGG ANTIBODY EIA
K002189 GLIADIN IGG ANTIBODY EIA DETECTION SYSTEM
K002169 GLIADIN IGA ANTIBODY EIA DETECTION SYSTEM
K002107 IFA KIT FOR THE DETECTION OF ENDOMYSIAL IGA ANIBODIES USING PRIMATE UMBILICAL CORD (PUC)-EMA/PUC LGA.
K994379 EU-TTG IGA ELISA
K970198 IFA HEP2 KIT FOR THE DETECTION OF ANTINUCLEAR ANTIBODIES
K962360 IFA KIT FOR THE DETECTION OF C-ANCA ANTIBODIES
Search all 14 clearances from Scimedx Corp. →